ClinicalTrials.gg
RecruitingNCT06248398ROBOT-IC-BRUITUpdated Feb 17, 2025

Impact of Robotic Cochlear Implantation on Hearing Performance in Noise

An interventional study of Surgery with RobOtol® and Conventional manual surgery in Severe to Profound Hearing Loss, sponsored by Assistance Publique - Hôpitaux de Paris. Recruiting at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-02-17.

Sponsored by Assistance Publique - Hôpitaux de Paris · Not applicable, Interventional, and Other

How we know

From the registry’s dates

  • Primary completion was expected by Dec 2025, 11 months ago, but the record still lists the study as recruiting.
  • Started Feb 2024; still recruiting 2 years 9 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
140
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 13 studies in Hearing Loss by Assistance Publique - Hôpitaux de Paris — 7 open to participants now, 7 under way, none of them phase 3. Hearing Loss · Assistance Publique - Hôpitaux de Paris.

Started
2024
with 1 other
No phase
3 of 13
2 open now
Registered
9th of 13
by date

Among the 13 studies in Hearing Loss by Assistance Publique - Hôpitaux de Paris, this one is one of 2 that started in 2024, is one of 3 with no phase, and was the 9th registered.

Hearing Loss

797 studies on the registry are indexed under Hearing Loss; 194 are open to participants now.

Browse Hearing Loss studies →

Open to participants now

7 of the 13 studies in Hearing Loss by Assistance Publique - Hôpitaux de Paris are open now, in 1 country. Recruiting first, the newest first:

1 more — sign in →

By country, each count listing its studies:

All 7 open studies →

Where they have run

Who these studies take

Of the 125 Hearing Loss studies recruiting now, 60 (48%) set no upper age limit and 43 (34%) stop at 75 or younger; 47 take children under 18; 46 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 13 studies in Hearing Loss by Assistance Publique - Hôpitaux de Paris, or all of them as a file.
02

Study summary

The purpose of this study is to compare two methods of cochlear implantation : conventional manual insertion versus robot-assisted in order to verify whether robotic insertion provides better performance in the noisy environment.

To do this, we will compare the two methods of insertion of the electrode holder, on 140 patients candidates for cochlear implantation randomized in two groups (70 conventional surgery versus 70 robot-assisted surgery). All patients will be recruited during 17 months, in our Ear, nose and throat (ENT) Department of the Pitié-Salpêtrière hospital group, the first center for adult patients established in France (on average 180 patients/year).

Patient will be followed for 9 months with clinical evaluation, imaging, audiometric, listening effort and quality of life assessments. These evaluations will be carried out preoperatively and postoperatively at 3 months and 6 months post-activation of the cochlear implant.

Read the detailed description

In the case of severe (70 to 90dB loss) and profound (>90dB loss) hearing loss, when conventional hearing aids no longer provide sufficient benefit, cochlear implantation remains the only possible solution for hearing rehabilitation. In implanted patients, a clear improvement in communication in silence is observed, but almost all patients have difficulty understanding speech in noisy environments. Cochlear implantation involves inserting an electrode holder into the cochlea during a surgical procedure under general anesthesia. The insertion of the electrode holder must be as minimally traumatic as possible in order to preserve the cochlear structures and avoid post-operative fibrosis that could impact the auditory outcomes.

The conventional method of this surgery is the manual insertion of the electrode holder. In recent years, robotic assistance, the RobOtol®, has been developed with the aim of avoiding the jerks of the surgeon's hand and improving the precision of the insertion. RobOtol® has had its CE marking since 2016 and is used in several hospitals in France and abroad.

03

Conditions studied

  • Severe to Profound Hearing Loss

Browse trials for

Keywords

  • Cochlear implant
  • Manual insertion
  • Robotic assistance insertion
  • Hearing understanding in noise
  • Quality of life
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adult patient ≥ 18 years old
  • Patients with an indication for uni or bilateral, simultaneous or sequential cochlear implantation: severe to profound bilateral deafness with intelligibility ≤70% for Fournier dissyllabic words, in free field, at 60dB with adapted hearing aids.
  • Patient able to understand the information note and give written consent
  • Affiliation to a French social security system

Exclusion criteria

Exclusion Criteria:

  • Patient who does not speak French
  • Etiologies of deafness known to be of bad prognosis (auditory neuropathy, congenital profound deafness, immediate post-meningitis profound deafness, vestibular schwannoma on the side of the ear to be implanted)
  • Impossibility of testing the effect of the cochlear implant alone on hearing results (cochlear implantation in the context of unilateral deafness or fluctuating deafness)
  • Cochlear implantation requiring the use of a perimodiolar electrode holder.
  • Pregnant and breastfeeding women
  • Patients wearing electronic devices, in direct connection with the brain or nervous system
  • Patient included in another interventional study (Jardé 1)
  • Patient under legal protection (guardianship or curatorship) or deprived of liberty
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
140 participants (estimated)

Study arms

  • Experimental
    Experimental arm

    Patient having cochlear implantation surgery with RobOtol®.

    Procedure: Surgery with RobOtol®

  • Other
    Control arm

    Patient having conventional manual cochlear implantation surgery.

    Procedure: Conventional manual surgery

Interventions

  • ProcedureSurgery with RobOtol®

    Patient having cochlear implantation surgery with RobOtol®.

  • ProcedureConventional manual surgery

    Patient having conventional manual cochlear implantation surgery

06

What researchers measure

Primary outcomes

  1. Auditory performance in noise with the cochlear implant

    Evolution of the intelligibility score (Variation of the percentage of words understood) for monosyllabic Lafon words presented at 60 dB SPL with a signal-to-noise ratio of 10 dB (SNR10) between the preoperative score and the score at 6 months post-implantation

    Time frame: At 6 months post-implantation

Secondary outcomes

  1. Hearing performance in noise after robotic cochlear implantation compared to conventional manual cochlear implantation for phonemes

    Evolution of the intelligibility score (Variation of the percentage of words and phonemes understood) for monosyllabic Lafon words presented at 60 dB SPL with a signal-to-noise ratio of 10 dB (SNR10) between the preoperative score and the score at 3 months and at 6 months post-implantation.

    Time frame: At 3 and 6 months post-implantation

  2. Hearing performance in noise under ecological conditions after robotic cochlear implantation compared to conventional manual cochlear implantation

    Evolution of the intelligibility score (Variation of the percentage of words understood) for Fr-Bio words presented at 60 dB SPL with a signal-to-noise ratio of 10 dB (SNR10) between the preoperative score and the score at 3 months and at 6 months post-implantation. The noise will be an ecological noise (restaurant or street noise) using the Immersion® system.

    Time frame: At 3 and 6 months post-implantation

  3. Hearing performance in silence after robotic cochlear implantation compared to conventional manual cochlear implantation for words

    Evolution of the intelligibility score (Variation of the percentage of words understood) for monosyllabic Lafon words presented at 60 dB SPL in quiet between the preoperative score and the score at 3 months and at 6 months post-implantation.

    Time frame: At 3 and 6 months post-implantation

  4. Hearing performance in silence after robotic cochlear implantation compared to conventional manual cochlear implantation for phonemes

    Evolution of the intelligibility score (Variation of the percentage of phonemes understood) for monosyllabic Lafon words presented at 60 dB SPL in quiet between the preoperative score and the score at 3 months and at 6 months post-implantation.

    Time frame: At 3 and 6 months post-implantation

  5. The subjective benefit on tinnitus after robotic cochlear implantation compared to conventional manual cochlear implantation

    Evolution of the Patient's Related Outcomes Measures using questionnaire concerning the tinnitus with the Tinnitus Handicap Inventory (THI)

    Time frame: At 3 and 6 months post-implantation

  6. The subjective benefit on quality of life after robotic cochlear implantation compared to conventional manual cochlear implantation

    Evolution of the Patient's Related Outcomes Measures using the questionnaire concerning the quality of life with the Cochlear Implant Quality of Life (CIQOL)

    Time frame: At 3 and 6 months post-implantation

  7. The position of the electrode array in the cochlea during manual and robotic insertions

    the position of each electrode will be analyzed blindly on the post-operative CT-scan.

    Time frame: At day one post -implantation

  8. The impact of a translocation on auditory performance in silence and in noise

    Auditory scores measured at 3 and 6 months after implantation will be correlated to the presence of a translocation of the electrode array assessed on the post-operative CT scan.

    Time frame: At 3 and 6 months post-implantation

  9. The effort of listening in silence and in noise after manual and robotic insertions assessed with the Speech, Spatial and Qualities of Hearing Scale (SSQ)

    The effort of listening will be analyzed with SSQ scale

    Time frame: At 3 and 6 months post-implantation

  10. The effort of listening in silence and in noise after manual and robotic insertions assessed with a visual analog scale

    The effort of listening will be analyzed after each audiologic test with a visual analog scale, using which the patient will rate from 0 to 10 the effort made to understand the words presented (Bräcker et al., 2019)

    Time frame: At 3 and 6 months post-implantation

  11. The preservation of residual hearing after cochlear implantation in cases with residual hearing before surgery

    Evolution of auditory thresholds measured with tonal audiometry between preoperative and postoperative measurements on the operated ear.

    Time frame: At 30 days, 3 months and 6 months post-implantation

  12. The presence of postoperative vertigo in case of robotic cochlear implantation compared to manual implantation

    Evaluation of vertigo with the Dizziness Handicap Inventory (DHI) questionnaire

    Time frame: At 7 days, 3 months and 6 months post-implantation

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes — The procedures carried out with the French data privacy authority (CNIL, Commission nationale de l'informatique et des libertés) do not provide for the transmission of the database, nor do the information and consent documents signed by the patients. Consultation by the editorial board or interested researchers of individual participant data that underlie the results reported in the article after deidentification may nevertheless be considered, subject to prior determination of the terms and conditions of such consultation and in respect for compliance with the applicable regulations.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form

Time frame: Beginning 3 months and ending 3 years following article publication. Requests out of these time frame can also be submitted to the sponsor

Access criteria: Researchers who provide a methodologically sound proposal.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Feb 2024 (actual). Primary completion is estimated for Dec 2025, 22 months after the start.

Of 197 non-industry interventional studies with no phase under Hearing Loss, half reached primary completion within 32 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 59. This study's planned 22 months is below that.

Counting every sponsor, half of 323 studies reached it within 19 months; a quarter within 5 and three quarters within 42.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 8, 2023
First posted
Feb 8, 2024
StartActual
Feb 20, 2024
Primary completionEst.
Dec 2025
CompletionEst.
Dec 2025
Last update
Feb 17, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 17, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06248398
Responsible party
Sponsor
First posted
Feb 8, 2024
Start date
Feb 20, 2024
Primary completion
Dec 2025 (estimated)
Completion
Dec 2025 (estimated)
Last update
Feb 17, 2025

Study contacts

Ghizlene LAHLOU, Dr
Contact
ghizlene.lahlou@aphp.fr
01 42 16 26 10
Isabelle MOSNIER, Dr
Contact
isabelle.mosnier@aphp.fr
01 42 16 26 10
Ghizlene LAHLOU, Dr
principal investigator · Assistance Publique - Hôpitaux de Paris

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion